Literature DB >> 2994072

Angiotensin II receptor binding sites in brain microvessels.

R C Speth, S I Harik.   

Abstract

We assessed the specific binding of 125I-labeled angiotensin II (125I-Ang II) to particulate fractions of the cerebral cortex and cerebellum and to microvessels obtained by bulk isolation from these two brain regions in the dog. 125I-Ang II binds to cerebral and cerebellar microvessels in a specific, saturable, and reversible manner and with high affinity (dissociation constant about 1 nM). Maximal binding of 125I-Ang II to brain microvessels was about 2-fold higher than the maximal binding to particulate fractions of the cerebellum and more than 15-fold higher than that of the cerebral cortex. No significant differences were noted between cerebral and cerebellar microvessels in their specific binding of Ang II. Furthermore, our finding that analogues of Ang II displace specific 125I-Ang II binding to brain microvessels in a rank order that correlates with their pharmacological activities confers biological relevance on the ligand-binding studies. These results strongly suggest that specific Ang II receptor binding sites are present in brain microvessels. Such Ang II receptors may have an important role in regulating the microcirculation of the brain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994072      PMCID: PMC391049          DOI: 10.1073/pnas.82.18.6340

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man.

Authors:  J H LARAGH; M ANGERS; W G KELLY; S LIEBERMAN
Journal:  JAMA       Date:  1960-09-17       Impact factor: 56.272

2.  Evidence for an endogenous brain renin-angiotensin system.

Authors:  M I Phillips; J Weyhenmeyer; D Felix; D Ganten; W E Hoffman
Journal:  Fed Proc       Date:  1979-08

3.  Peptidyl dipeptidase in rabbit brain microvessels.

Authors:  P Brecher; A Tercyak; H Gavras; A V Chobanian
Journal:  Biochim Biophys Acta       Date:  1978-10-12

4.  Effects of angiotensin II on fluid transport, transmural potential difference and blood flow by rat jejunum in vivo.

Authors:  J E Bolton; K A Munday; B J Parsons; B G York
Journal:  J Physiol       Date:  1975-12       Impact factor: 5.182

5.  Effects of angiotensin II on cerebral blood vessels.

Authors:  L Edvinsson; J E Hardebo; C Owman
Journal:  Acta Physiol Scand       Date:  1979-03

6.  Effects of angiotensin II and some analogues on vascular permeability in the rabbit.

Authors:  A L Robertson; P A Khairallah
Journal:  Circ Res       Date:  1972-12       Impact factor: 17.367

7.  Angiotensin II and alpha-adrenergic agonists inhibit rat liver adenylate cyclase.

Authors:  S Jard; B Cantau; K H Jakobs
Journal:  J Biol Chem       Date:  1981-03-25       Impact factor: 5.157

8.  Vasoconstrictor effect of angiotensin on pial arteries.

Authors:  E P Wei; H A Kontos; J L Patterson
Journal:  Stroke       Date:  1978 Sep-Oct       Impact factor: 7.914

9.  beta-Adrenergic regulation of adenosine 3',5'-monophosphate concentration in brain microvessels.

Authors:  T J Herbst; M E Raichle; J A Ferrendelli
Journal:  Science       Date:  1979-04-20       Impact factor: 47.728

10.  Angiotensin II binding to mammalian brain membranes.

Authors:  J P Bennett; S H Snyder
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

View more
  12 in total

Review 1.  Angiotensin and cerebral blood flow.

Authors:  J M Saavedra; Y Nishimura
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

2.  Effects of selected vasoactive substances on adenylate cyclase activity in brain, isolated brain microvessels, and primary cultures of brain microvessel endothelial cells.

Authors:  A Baranczyk-Kuzma; K L Audus; F L Guillot; R T Borchardt
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

3.  Quantitative receptor autoradiographic analysis for angiotensin II receptors in bovine retinal microvessels: quantitation with radioluminography.

Authors:  T Sato; M Niwa; A Himeno; K Tsutsumi; T Amemiya
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

4.  Selective C1 Lesioning Slightly Decreases Angiotensin II Type I Receptor Expression in the Rat Rostral Ventrolateral Medulla (RVLM).

Authors:  Erick A Bourassa; Kristen A Stedenfeld; Alan F Sved; Robert C Speth
Journal:  Neurochem Res       Date:  2015-07-03       Impact factor: 3.996

Review 5.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

6.  Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography.

Authors:  S Yamaga; K Tsutsumi; M Niwa; N Kitagawa; T Anda; A Himeno; H Khalid; K Taniyama; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1995-06       Impact factor: 5.046

7.  Specific binding of atrial natriuretic factor in brain microvessels.

Authors:  P E Chabrier; P Roubert; P Braquet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Angiotensin II, vasopressin and GTP[gamma-S] inhibit inward-rectifying K+ channels in porcine cerebral capillary endothelial cells.

Authors:  J Hoyer; R Popp; J Meyer; H J Galla; H Gögelein
Journal:  J Membr Biol       Date:  1991-07       Impact factor: 1.843

9.  Permeability and mechanism of albumin, cationized albumin, and glycosylated albumin transcellular transport across monolayers of cultured bovine brain capillary endothelial cells.

Authors:  K R Smith; R T Borchardt
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

10.  AT1 receptor characteristics of angiotensin analogue binding in human synovium.

Authors:  D A Walsh; T Suzuki; G A Knock; D R Blake; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.